USAN Council's statement on the use of USAN as domain names is that a name published by the United States Adopted Names (USAN) Program in the USP Dictionary of USAN and International Nonproprietary Names, and on the United States Adopted Names website shall be the effective equivalent of an intellectual property right for the relevant entities.
Visit United States Adopted Names FAQ to learn more.
Comments or protests should be addressed to Stephanie Shubat, USAN program director, American Medical Association, 330 North Wabash Ave., Suite 39300, Chicago, Illinois 60611, or via email: [email protected].
In order to ensure your "under consideration" USAN domain name is available, you should consider purchasing the .com, .net and .org domain names of the USAN under consideration. The optimal time to do this is when you receive the letter from the USAN Program informing you of the USAN Council's naming decision.
The following names for the drugs described are "under consideration" by the USAN Council:
May 2026
Amrecibart: Prevention and treatment of thromboembolic diseases
Atebimetinib: Antineoplastic, treatment of solid tumors
Bocunebart: Treatment of headache, migraine and other conditions that may benefit from the neutralization of PACAP
Cenvacibart: Prevention and treatment of thromboembolic diseases
Darlifarnib: Treatment of advanced solid tumors
Elisrasib: Antineoplastic, treatment of advanced solid tumors
Elecoglipron: Treatment of type 2 diabetes and weight management
Giredestrant tartrate: Treatment of cancer
Ifezuntirgene inilparvovec: Treatment of Huntington’s Disease
Mazorelvimab: Treatment for rabies virus (RABV) infections
Mivocabtagene autoleucel: Treatment of Stiff Person Syndrome (SPS)
Mosliciguat: Treatment of pulmonary hypertension
Nexiguran: Treatment of transthyretin amyloidosis (ATTR)
Nuzefatide: Treatment of patients with EphA2 expressing tumors
Nuzefatide pevedotin: Treatment of patients with EphA2 expressing tumors
Palacaparib: Treatment of advanced solid tumors
Pivodisgene parvec: Treatment of Duchenne muscular dystrophy (DMD)
Resecabtagene autoleucel: Treatment of systemic lupus erythematosus (SLE), idiopathic inflammatory myopathy (IIM, or myositis), systemic sclerosis (SSc), and other B cell driven autoimmune diseases
Sasineprocel: Treatment of Parkinson’s disease
Soclenicant: Treatment of anxiety-, trauma-, and stressor-related disorders
Velaprumig: Treatment of thyroid eye disease (TED, Graves’ ophthalmopathy)
Zamerovimab: Treatment against rabies virus infections
Zeprumetostat: Antineoplastic
Ziclumeran: Treatment of transthyretin amyloidosis (ATTR)
April 2026
Actinium ac255 ancelvotide guraxetan: Antineoplastic, Treatment of prostate cancer
Agazisiran: Treatment of paroxysmal nocturnal hemoglobinuria (PNH)
Agazisiran sodium: reatment of paroxysmal nocturnal hemoglobinuria (PNH)
Alixorexton: Treatment of narcolepsy and idiopathic hypersomnia
Cafraglutide: Treatment of obesity
Camupepimut: Treatment of Kirsten rat sarcoma (KRAS) or neuroblastoma ras (NRAS) viral oncogene homolog mutated solid tumors
Elecoglipron: Treatment of type 2 diabetes and weight management
Gatuzosiran: Treatment of Metabolic dysfunction-associated steatohepatitis (MASH) and Chronic alcohol-related liver disease (ALD)
Gatuzosiran sodium: Treatment of Metabolic dysfunction-associated steatohepatitis (MASH) and Chronic alcohol-related liver disease (ALD)
Iodofalan I 131: Treatment agent for malignant gliomas
Lanifibranor: Treatment of nonalcoholic steatohepatitis (NASH), also called metabolic dysfunction associated with steatohepatitis (MASH)
Liraltagene autoleucel: Treatment of ovarian cancer
Lysergide: Treatment of anxiety and depression
Lysergide tartrate: Treatment of anxiety and depression
Maridebart: Treatment of obesity
Maridebart cafraglutide: Treatment of obesity
Navlimetostat: Antineoplastic
Olatansine: Antineoplastic, treatment of folate receptor alfa (Fra) positive tumors
Opugotamig: Antineoplastic, treatment of folate receptor alfa (Fra) positive tumors
Opugotamig olatansine: Antineoplastic, treatment of folate receptor alfa (Fra) positive tumors
Pivicasiran: Treatment of metabolic dysfunction-associated steatotic liver disease (MASLD)
Surabgene lomparvovec: Treatment of neovascular age-related macular degeneration (nAMD, also known as "wet" AMD) and diabetic retinopathy (DR)
March 2026
Cagrilintide hydrochloride: Weight management aid
Cliramitug: Treatment of transthyretin amyloidosis cardiomyopathy (ATTR-CM) and transthyretin amyloidosis polyneuropathy (ATTR-PN)
Dapiglutide: Treatment of obesity
Deulumateperone: Treatment of psychosis
Deulumateperone tosylate: Treatment of psychosis
Elegrobart: Treatment of thyroid eye disease (TED)
Evarucabgene autoleucel: Treatment of relapsed/refractory AL amyloidosis, with the potential to expand into select immunemediated diseases
Faldoritinib: Treatment of cancer including Acute myeloid leukemia (AML)
Florensocatib: Treatment of non-cystic fibrosis bronchiectasis (NCFBE)
Imeroprubart: Treatment of immunoglobulin (Ig)G-mediated autoimmune diseases
Ixotatug: Antineoplastic
Ixotatug vedotin: Antineoplastic
Lunsotogene parvec: Treatment of OTOF-related congenital hearing loss due to congenital auditory neuropathy
Napazimone: Treatment of primary mitochondrial disease
Ontunisertib: Treatment of inflammatory bowel disease (IBD)
Onvuzosiran: Treatment of hereditary angioedema (HAE)
Onvuzosiran sodium: Treatment of hereditary angioedema (HAE)
Ozureprubart: Treatment of allergic asthma, food allergies, chronic spontaneous urticaria, and other allergic inflammatory diseases
Pegtarazimod: Treatment of hypoxic ischemic encephalopathy (HIE), acute COPD exacerbations, and acute graft vs. host disease
Pegtarazimod hydrochloride: Treatment of hypoxic ischemic encephalopathy (HIE), acute COPD exacerbations, and acute graft vs. host disease
Pevifoscorvir: Treatment of Chronic Hepatitis B Infection; Chronic Hepatitis D Infection
Ponometrep: Treatment of migraine, neuropathic pain, and nociceptive pain
Relzasertideg: Treatment of refractory or recurrent Acute Myeloid Leukemia (AML)
Remlifanserin: Treatment of schizophrenia and the hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP)
Retogatein: Treatment and prevention of autoimmune diabetes, including type 1 diabetes and latent autoimmune diabetes
Rocavorexant: Treatment of opioid use disorder (OUD)
Sevoloprubart: Treatment of autoimmune disorders
Tersolisib: Treatment of HR+, HER2-breast cancer
Zocilurtatug: Antineoplastic, treatment of small-cell lung cancer (SCLC)
